These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15235029)

  • 1. Genetic susceptibility in familial melanoma from northeastern Italy.
    Landi MT; Goldstein AM; Tsang S; Munroe D; Modi W; Ter-Minassian M; Steighner R; Dean M; Metheny N; Staats B; Agatep R; Hogg D; Calista D
    J Med Genet; 2004 Jul; 41(7):557-66. PubMed ID: 15235029
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic and environmental factors in cutaneous malignant melanoma.
    Bressac-de-Paillerets B; Avril MF; Chompret A; Demenais F
    Biochimie; 2002 Jan; 84(1):67-74. PubMed ID: 11900878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genes involved in melanoma: an overview of INK4a and other loci.
    Castellano M; Parmiani G
    Melanoma Res; 1999 Oct; 9(5):421-32. PubMed ID: 10596908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
    Soufir N; Avril MF; Chompret A; Demenais F; Bombled J; Spatz A; Stoppa-Lyonnet D; Bénard J; Bressac-de Paillerets B
    Hum Mol Genet; 1998 Feb; 7(2):209-16. PubMed ID: 9425228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of inherited predisposition to melanoma.
    Cannon-Albright LA; Kamb A; Skolnick M
    Semin Oncol; 1996 Dec; 23(6):667-72. PubMed ID: 8970585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
    Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA
    Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.
    FitzGerald MG; Harkin DP; Silva-Arrieta S; MacDonald DJ; Lucchina LC; Unsal H; O'Neill E; Koh J; Finkelstein DM; Isselbacher KJ; Sober AJ; Haber DA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8541-5. PubMed ID: 8710906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of germline CDKN2A, ARF, CDK4, PTEN, and BRAF alterations in atypical mole syndrome.
    Celebi JT; Ward KM; Wanner M; Polsky D; Kopf AW
    Clin Exp Dermatol; 2005 Jan; 30(1):68-70. PubMed ID: 15663508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of susceptibility gene variants to melanoma risk in families from the Veneto region of Italy.
    Menin C; Vecchiato A; Scaini MC; Elefanti L; Funari G; De Salvo GL; Quaggio M; Tognazzo S; Agata S; Dalla Santa S; Montagna M; Alaibac M; Chiarion-Sileni V; D'Andrea E
    Pigment Cell Melanoma Res; 2011 Aug; 24(4):728-30. PubMed ID: 21672182
    [No Abstract]   [Full Text] [Related]  

  • 11. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
    Soufir N; Bressac-de Paillerets B; Desjardins L; Lévy C; Bombled J; Gorin I; Schlienger P; Stoppa-Lyonnet D
    Br J Cancer; 2000 Feb; 82(4):818-22. PubMed ID: 10732752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.
    Bahuau M; Vidaud D; Jenkins RB; Bièche I; Kimmel DW; Assouline B; Smith JS; Alderete B; Cayuela JM; Harpey JP; Caille B; Vidaud M
    Cancer Res; 1998 Jun; 58(11):2298-303. PubMed ID: 9622062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma.
    Laud K; Marian C; Avril MF; Barrois M; Chompret A; Goldstein AM; Tucker MA; Clark PA; Peters G; Chaudru V; Demenais F; Spatz A; Smith MW; Lenoir GM; Bressac-de Paillerets B;
    J Med Genet; 2006 Jan; 43(1):39-47. PubMed ID: 15937071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of familial atypical multiple mole-melanoma (FAMMM) syndrome in The Netherlands: how far have we come?
    Gruis NA; Van der Velden PA; Bergman W; Frants RR
    Bull Cancer; 1998 Jul; 85(7):627-30. PubMed ID: 9752270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival.
    Grafström E; Egyházi S; Ringborg U; Hansson J; Platz A
    Clin Cancer Res; 2005 Apr; 11(8):2991-7. PubMed ID: 15837753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Of mice and humans. Updates on susceptibility and tumor suppression of malignant melanoma].
    Hautarzt; 2002 Jan; 53(1):88-9. PubMed ID: 11968172
    [No Abstract]   [Full Text] [Related]  

  • 17. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors.
    Sotillo R; Dubus P; Martín J; de la Cueva E; Ortega S; Malumbres M; Barbacid M
    EMBO J; 2001 Dec; 20(23):6637-47. PubMed ID: 11726500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
    Sonoda Y; Yoshimoto T; Sekiya T
    Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of familial cutaneous melanoma.
    Haluska FG; Hodi FS
    J Clin Oncol; 1998 Feb; 16(2):670-82. PubMed ID: 9469357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
    Newton Bishop JA; Harland M; Bennett DC; Bataille V; Goldstein AM; Tucker MA; Ponder BA; Cuzick J; Selby P; Bishop DT
    Br J Cancer; 1999 Apr; 80(1-2):295-300. PubMed ID: 10390011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.